Clinical Study on Pathogenic Diagnosis of Mycobacterium Dermatis Infectious Granuloma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078815

Enrollment

Unknown

Registered

2023-12-19

Start date

2022-06-28

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycobacterium Dermatis Infectious Granuloma

Interventions

Gold Standard:Clinical manifestations related to cutaneous mycobacterium infection

Mycobacterium culture of biopsy tissue

Index test:polymerase chain reaction diagnosis

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age greater than 18 years old, regardless of gender (2) Clinical manifestations in dermatology include chronic ulcers, plaques, and nodular skin lesions arranged along lymphatic vessels; Patients with local infection after cosmetic injection or plastic surgery; Patients with local nodules and plaques after tattooing. One of the above standards is sufficient. (3) Agree to accept biopsy and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Subjects who meet any of the following criteria will be excluded from this trial (1) Pregnant or lactating patients; (2) Severe liver and kidney dysfunction or coagulation disorders, or accompanied by other serious systemic diseases; (3) Patients who do not agree to biopsy sampling; (4) Researchers believe that other participants are not suitable for the experiment.

Design outcomes

Primary

Measure	Time frame
polymerase chain reaction diagnosis;	—

Countries

CHINA

Contacts

Public ContactDegang Yang

Shanghai Dermatology Hospital/Tongji University Affiliated Dermatology Hospital

ydg007@aliyun.com+86 180 1733 6893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026